CAD 0.01
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -2.95 Million CAD | 73.96% |
2022 | -4.06 Million CAD | -154.7% |
2021 | -17.52 Million CAD | 224.7% |
2020 | -10.95 Million CAD | 59.45% |
2019 | -40.96 Million CAD | -179.88% |
2018 | -14.63 Million CAD | -51551.33% |
2017 | 28.45 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -2.02 Million CAD | -44.13% |
2024 Q1 | -1.4 Million CAD | 76.36% |
2023 Q2 | 486.11 Thousand CAD | 173.32% |
2023 Q4 | -1.81 Million CAD | -378.72% |
2023 FY | - CAD | 73.96% |
2023 Q3 | -379.59 Thousand CAD | -178.09% |
2023 Q1 | -663 Thousand CAD | 94.83% |
2022 Q1 | -3 Million CAD | -108.68% |
2022 FY | - CAD | -154.7% |
2022 Q3 | -4.18 Million CAD | -147.07% |
2022 Q2 | 8.89 Million CAD | 395.6% |
2022 Q4 | -12.82 Million CAD | -206.31% |
2021 Q2 | -3.22 Million CAD | 29.64% |
2021 FY | - CAD | 224.7% |
2021 Q1 | -4.58 Million CAD | -3577.56% |
2021 Q3 | -6.05 Million CAD | -87.93% |
2021 Q4 | 34.67 Million CAD | 672.47% |
2020 FY | - CAD | 59.45% |
2020 Q1 | -7.5 Million CAD | 68.82% |
2020 Q4 | 131.73 Thousand CAD | 102.88% |
2020 Q3 | -4.57 Million CAD | 1.65% |
2020 Q2 | -4.65 Million CAD | 38.01% |
2019 Q1 | -7.64 Million CAD | -270.54% |
2019 FY | - CAD | -179.88% |
2019 Q4 | -24.08 Million CAD | -386.69% |
2019 Q3 | -4.94 Million CAD | -15.4% |
2019 Q2 | -4.28 Million CAD | 43.91% |
2018 Q3 | -9.92 Million CAD | -373.22% |
2018 FY | - CAD | -51551.33% |
2018 Q4 | -2.06 Million CAD | 79.22% |
2018 Q1 | -586.95 Thousand CAD | -2163.1% |
2018 Q2 | -2.09 Million CAD | -257.47% |
2017 FY | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | 28.45 Thousand CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | 51.418% |
Ayurcann Holdings Corp. | -2.01 Million CAD | -46.766% |
Blueberries Medical Corp. | -1.22 Million CAD | -141.508% |
The BC Bud Corporation | -1.19 Million CAD | -146.713% |
BioNxt Solutions Inc. | -6.48 Million CAD | 54.497% |
CordovaCann Corp. | -1.6 Million CAD | -84.119% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | -12.475% |
Captor Capital Corp. | 2.42 Million CAD | 221.872% |
City View Green Holdings Inc. | -2.01 Million CAD | -46.477% |
1CM Inc. | 1.31 Million CAD | 324.641% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -11801.412% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -33.614% |
IM Cannabis Corp. | -2.79 Million CAD | -5.76% |
Lobe Sciences Ltd. | -4.4 Million CAD | 32.973% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -652.319% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 7.588% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 358.472% |
Ovation Science Inc. | -778.83 Thousand CAD | -278.864% |
Pharmadrug Inc. | -1.33 Million CAD | -121.025% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | 51.277% |
RAMM Pharma Corp. | -6.3 Million CAD | 53.179% |
RIV Capital Inc. | -20.28 Million CAD | 85.45% |
Revive Therapeutics Ltd. | -5.59 Million CAD | 47.262% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 96.197% |
1933 Industries Inc. | -10.03 Million CAD | 70.59% |
Red Light Holland Corp. | -5.25 Million CAD | 43.858% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -284.211% |
Xebra Brands Ltd. | -1.49 Million CAD | -97.373% |
Adastra Holdings Ltd. | -1.41 Million CAD | -109.083% |